The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients-Reference-Cited by-同舟云学术

The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients

Published:2019-04-04 Issue:1 Volume:19 Page:
ISSN:1475-2867
Container-title:Cancer Cell International
language:en
Short-container-title:Cancer Cell Int

Author:

Salehzadeh Serena^ORCID,Guerrini Francesca,Pizzano Umberto,Grassi Susanna,Ciabatti Elena,Iovino Lorenzo,Buda Gabriele,Caracciolo Francesco,Benedetti Edoardo,Orciuolo Enrico,Pelosini Matteo,Consani Giovanni,Carulli Giovanni,Metelli Maria Rita,Martini Francesca,Mazziotta Francesco,Mazzantini Elisa,Rossi Pietro,Tavarozzi Rita,Ricci Federica,Petrini Mario,Galimberti Sara

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12935-019-0807-0.pdf

Reference60 articles.

1. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.

2. Schuurhuis GJ, Heuser M, Freeman S, Béné M-C, Buccisano F, Cloos J, et al. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2018;131:1275–91.

3. Micol JB, Boissel N, Renneville A, Castaigne S, Gardin C, Preudhomme C, et al. The role of cytogenetic abnormalities in acute myeloid leukemia with NPM1 mutations and no FLT3 internal tandem duplication. Blood. 2009;114:4601–2 (author reply 4602-4603).

4. Haferlach C, Mecucci C, Schnittger S, Kohlmann A, Mancini M, Cuneo A, et al. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features. Blood. 2009;114:3024–32.

5. Gale RE, Green C, Allen C, Mead AJ, Burnett AK, Hills RK, et al. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood. 2008;111:2776–84.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WT1 And DNMT3A Mutations in Prognostic Significance of Acute Myeloid Leukemia: A Meta-Analysis;Cancer Biotherapy and Radiopharmaceuticals;2024-08-29

2. Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease;Leukemia Research Reports;2021

3. Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients;Cancers;2020-06-30

4. Trisomy 8 in acute myeloid leukemia;Expert Review of Hematology;2019-09-26